Myocardial Infarction following Administration of Sublingual Ergotamine

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 1982 English Publisher:Elsevier BVJournal:Chest, volume 82, pages 375-376 (issn: 0012-3692,

Copyright policy )

Authors: L S, Klein; R J, Simpson; R, Stern; J C, Hayward; J R, Foster;

doi: 10.1378/chest.82.3.375

pmid: 7105868

Myocardial Infarction following Administration of Sublingual Ergotamine

- Summary
- Subjects
- Metrics

Abstract

Ergotamine is commonly used in the treatment of migraine headache. Since migraine may be associated with variant angina, some patients with migraine may develop coronary ischemia following therapy with ergotamine. We describe a young woman with migraine who had two myocardial infarctions following low dose sublingual ergotamine. We feel that the ergotamine was an important precipitating cause in both infarctions.

Related Organizations

University of North Carolina at Chapel Hill
United States

Keywords

Adult, Migraine Disorders, Ergotamine, Myocardial Infarction, Administration, Oral, Humans, Female, Mouth Floor

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	7
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average